TrialPloS one2016

An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.

Rob Lambkin-Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.